Literature DB >> 10948065

Ischemic preconditioning activates phosphatidylinositol-3-kinase upstream of protein kinase C.

H Tong1, W Chen, C Steenbergen, E Murphy.   

Abstract

The present study is designed to test whether phosphatidylinositol 3-kinase (PI3-kinase) has a role in the signaling pathway in ischemic preconditioning (PC) and whether it is proximal or distal to protein kinase C (PKC). Before 20 minutes of global ischemia, Langendorff-perfused rat hearts were perfused for 20 minutes (control); preconditioned with 4 cycles of 5-minute ischemia and 5-minute reflow (PC); treated with either wortmannin (WM) or LY 294002 (LY), each of which is a PI3-kinase inhibitor, for 5 minutes before and throughout PC; treated with 1,2-dioctanoyl-sn-glycerol (DOG), an activator of PKC for 10 minutes (DOG); treated identically to the DOG group except with WM added 10 minutes before and during perfusion with DOG; or treated with either WM or LY for 25 minutes. Recovery of left ventricular developed pressure (LVDP; percentage of initial preischemic LVDP), measured after 30 minutes of reflow, was improved by PC (72+/-2% versus 36+/-4% in control; P<0.001), and this was blocked by WM and LY (41+/-4% and 43+/-5%, respectively; P<0.05 compared with PC). DOG addition improved postischemic LVDP (67+/-6%; P<0.001 compared with control), but in contrast to its effect on PC, WM did not completely eliminate the protective effect of DOG (52+/-4%; P>0.05 compared with DOG; P<0.05 compared with control). PC induced phosphorylation of protein kinase B and translocation of PKC epsilon, and it increased NO production, and these effects were blocked by WM, which suggests a role for PI3-kinase in PC upstream of PKC and NO.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10948065     DOI: 10.1161/01.res.87.4.309

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  82 in total

Review 1.  PPARgamma as a potential therapeutic target in pulmonary hypertension.

Authors:  Roy L Sutliff; Bum-Yong Kang; C Michael Hart
Journal:  Ther Adv Respir Dis       Date:  2010-06       Impact factor: 4.031

Review 2.  Efficacy of preconditioning should be gauged by reduction of infarction.

Authors:  Michael V Cohen
Journal:  Br J Pharmacol       Date:  2004-01       Impact factor: 8.739

3.  Phosphoinositide 3-kinase gamma/delta inhibition limits infarct size after myocardial ischemia/reperfusion injury.

Authors:  John Doukas; Wolfgang Wrasidlo; Glenn Noronha; Elena Dneprovskaia; Richard Fine; Sara Weis; John Hood; Anthony Demaria; Richard Soll; David Cheresh
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-15       Impact factor: 11.205

4.  Ischemic preconditioning-induced cardioprotection is lost in mice with immunoproteasome subunit low molecular mass polypeptide-2 deficiency.

Authors:  Zheqing P Cai; Zhenyun Shen; Luc Van Kaer; Lewis C Becker
Journal:  FASEB J       Date:  2008-08-26       Impact factor: 5.191

Review 5.  Nuclear and mitochondrial signalling Akts in cardiomyocytes.

Authors:  Shigeki Miyamoto; Marta Rubio; Mark A Sussman
Journal:  Cardiovasc Res       Date:  2009-03-11       Impact factor: 10.787

Review 6.  Designing drug regimens for special intensive care unit populations.

Authors:  Brian L Erstad
Journal:  World J Crit Care Med       Date:  2015-05-04

7.  NO mobilizes intracellular Zn2+ via cGMP/PKG signaling pathway and prevents mitochondrial oxidant damage in cardiomyocytes.

Authors:  Youngho Jang; Huihua Wang; Jinkun Xi; Robert A Mueller; Edward A Norfleet; Zhelong Xu
Journal:  Cardiovasc Res       Date:  2007-05-17       Impact factor: 10.787

8.  Pivotal role of mTORC2 and involvement of ribosomal protein S6 in cardioprotective signaling.

Authors:  Toshiyuki Yano; Marcella Ferlito; Angel Aponte; Atsushi Kuno; Tetsuji Miura; Elizabeth Murphy; Charles Steenbergen
Journal:  Circ Res       Date:  2014-02-20       Impact factor: 17.367

9.  Transcriptional responses in the adaptation to ischaemia-reperfusion injury: a study of the effect of ischaemic preconditioning in total knee arthroplasty patients.

Authors:  Terence Murphy; Pauline M Walsh; Peter P Doran; Kevin J Mulhall
Journal:  J Transl Med       Date:  2010-05-10       Impact factor: 5.531

10.  Mitochondrial cyclophilin-D as a critical mediator of ischaemic preconditioning.

Authors:  Derek J Hausenloy; Shiang Y Lim; Sang-Ging Ong; Sean M Davidson; Derek M Yellon
Journal:  Cardiovasc Res       Date:  2010-04-16       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.